← All organizations

NuPathe Inc.

For profitWebsite ↗

Also known as: NuPathe

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 1, 2013

Acquired by Endo Pharmaceuticals → Mallinckrodt (2013) on Jan 1, 2013

Timeline

2000s

Jun 1, 2005
NuPathe Inc.— Founded

2010s

Jan 1, 2013
Endo Pharmaceuticals— Acquired By

2020s

Mar 1, 2025
Mallinckrodt (2013)— Now

Drugs by trial phase (1 distinct, 8 trials)

Phase 3 (1 own, 0 via acquisition)

sumatriptan

Indications

Studied for

Migraine Disorders

Recent trials (11)

NCT02684409Lead sponsorPhase 1Aug 1, 2013
NCT01381796Lead sponsorPhase 1Dec 1, 2009
NCT00806546Study directorPhase 3Feb 1, 2009
NCT00806546Lead sponsorPhase 3Feb 1, 2009
NCT00724815Lead sponsorPhase 3Jan 1, 2009
NCT00792103Study chairPhase 3Jan 1, 2009
NCT00792103Lead sponsorPhase 3Jan 1, 2009
NCT00724815Study directorPhase 3Jan 1, 2009
NCT00723983Lead sponsorPhase 1Nov 1, 2008
NCT00720018Lead sponsorPhase 1Jun 1, 2008
NCT00546650Lead sponsorPhase 1Nov 1, 2007

Details

Founded: Malvern, PA, US Jun 1, 2005
Last known activity: Aug 1, 2013